Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × ruxolitinib × Clear all

Phase

Status

Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Primary Myelofibrosis 6 Myeloproliferative Disorders 6 Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myelodysplastic Syndromes 5 Thrombocythemia, Essential 4 Recurrence 4 Polycythemia Vera 4 Multiple Myeloma 4 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Leukemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma 2 Leukemia, Prolymphocytic, T-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Large Granular Lymphocytic 2 Hematologic Neoplasms 2 Graft vs Host Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Targeted Therapy 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 46 Specimen Handling 30 Magnetic Resonance Spectroscopy 27 Biopsy 26 Radiosurgery 19 Gemcitabine 14 Nivolumab 13 Cisplatin 13 Paclitaxel 11 Carboplatin 11 Cyclophosphamide 10 Taxes 9 Pemetrexed 9 Leucovorin 9 Irinotecan 9 Fluorouracil 9 Capecitabine 9 Oxaliplatin 8 Drug Therapy 8 Doxorubicin 8 Cetuximab 8 Bevacizumab 8 trastuzumab deruxtecan 7 Radiotherapy 7 olaparib 6 cemiplimab 6 abemaciclib 6 Standard of Care 6 Folfox protocol 6 Docetaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06397313 2025-09-23

POTAMI-61

Ryvu Therapeutics SA

Phase 2 Recruiting

Neoplasm Metastasis, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡